Moreover, an in vitro model of sorafenib resistant HCC showed that sterol-regulatory element binding protein (SREBP) cleavage-activating protein (SCAP)-derived sorafenib resistance was associated with a lower autophagy activation [41]. This evidence concerns the gene CNBP and hepatocellular carcinoma.